Sonoma Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $6,406 | $5,561 | $4,349 | $5,604 |
Gross Profit | 2,577 | 2,181 | 1,650 | 2,120 |
EBITDA | -330 | -318 | -644 | -301 |
EBIT | -351 | -678 | -337 | |
Net Income | -330 | -581 | -819 | -534 |
Net Change In Cash | 6,406 | 5,561 | 4,349 | 5,604 |
Free Cash Flow | -651 | -548 | -811 | -142 |
Cash | 5,338 | 2,399 | 2,561 | 3,035 |
Basic Shares | 3,846 | 1,764 | 1,713 | 1,646 |
Annual Financials
| Values in thousands | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
Revenue | $19,529 | $14,288 | $12,735 | $13,272 |
Gross Profit | 7,415 | 5,465 | 4,745 | 4,477 |
EBITDA | -2,322 | -2,769 | -4,855 | -5,059 |
EBIT | -2,461 | -2,907 | -5,031 | -5,184 |
Net Income | -3,175 | -3,457 | -4,835 | -5,151 |
Net Change In Cash | 19,529 | 14,288 | 12,735 | 13,272 |
Free Cash Flow | -4,125 | -168 | -2,415 | -6,421 |
Cash | 2,399 | 5,374 | 3,128 | 3,820 |
Basic Shares | 1,684 | 1,241 | 909 | 339 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.02 |
2026-03-31 | -$0.15 |
2025-12-31 | -$0.48 |
2025-09-30 | -$0.32 |